Search Results

Sysmex America, Inc. announces its plan to sell hemostasis instruments and reagents to laboratories in the United States beginning in April, under the company’s mutual OEM agreement with Siemens Healthineers.

Sysmex America, Inc., a leading diagnostic solutions company, has been named the exclusive distributor of vermicon identification technology System in Canada, Latin America and all the Americas.

Inc. Magazine has named trailblazing life sciences company Xenco Medical one of the best companies to work for in America.

Mitsubishi Tanabe Pharma America, Inc. is aware of recent external challenges facing the amyotrophic lateral sclerosis treatment landscape.

Sysmex America, Inc. announced that Chris Cappella has joined the Company as Chief Financial Officer.

Bionet America, Inc. announced the launch of the new Brio XVet series, a groundbreaking line of multiparameter monitors for use in veterinary surgery.

RxSight, Inc., an ophthalmic medical device company dedicated to providing high-quality customized vision to patients following cataract surgery, announced plans to participate in the upcoming Bank of America Healthcare Conference.

Fujirebio Holdings, Inc. and Sysmex Corporation announced that they have signed an agreement for the mutual supply of reagent raw materials owned by both companies.

Fujirebio Holdings, Inc. and Sysmex Corporation announced that they have entered into an agreement to expand their Contract Development and Manufacturing Organization partnership for Sysmex’s Automated Immunoassay System HISCL™-Series to include the field of neurodegenerative diseases, following the discussion based on the Basic Agreement on Business Collaboration in the field of immunoassay signed in October 2023*.